This year, Multiple Sclerosis News Today offered expanded coverage of the 2016 Annual Meeting of the Consortium of Multiple Sclerosis [...]
Researchers at the Swedish Neuroscience Institute in Washington and Novartis Pharma revealed that Gilenya (fingolimod) induced a [...]
Understanding and combining decision-making processes of both patients with multiple sclerosis (MS) and physical therapists to improve [...]
Most research in multiple sclerosis (MS) has focused on the impact of the disease on the lower extremities. To balance this, researchers [...]
Mindy Eisenberg is the author of the book “Adaptive Yoga Moves Any Body” and Multiple Sclerosis News Today had the chance to hear [...]
Data recently presented at the Consortium of Multiple Sclerosis Centers (CMSC) 2016 Annual Meeting showed that Roche/Genentech’s [...]
EMD Serono, the U.S. and Canadian subsidiary and biopharmaceutical business of Merck KGaA, focuses exclusively on specialty care. With [...]
We are extremely pleased to tell you that Kessler Foundation has been ranked #5 on a list of the “50 Best Workplaces for Recent College [...]
With an interest multiple sclerosis (MS) before even starting college, Dr. Ellen Mowry has spent her entire research career investigating [...]
Patients with multiple sclerosis (MS) have increased levels of the neurotransmitter glutamate in their brains, lowering the levels of [...]